Australia Won't Oppose Sika-MBCC Deal, Subject to Divestment Conditions
By Pierre Bertrand
Australia's competition and consumer commission said Thursday that it won't oppose Sika's takeover of MBCC Group on the condition that the Swiss specialty-chemical company divests MBCC assets.
The Australian Competition and Consumer Commission said it wouldn't oppose the deal if Sika, under a court-enforced plan, divests all of MBCC's business in Australia and New Zealand including Bluey Technologies and divests MBCC's admixtures business in Europe, Switzerland, the U.K., the U.S. and Canada.
The divestments are part of a remedy process to address global competition concerns related to Sika's 5.5 billion Swiss francs ($6.13 billion) takeover announced in November 2021.
Sika's plan has received conditional approval from the European Commission. Last month, the company said the U.K.'s Competition and Markets Authority had accepted that Sika divest MBCC assets to international private-equity firm Cinven.
Sika had originally intended to dispose of the assets to Ineos Enterprises, but changed tack following provisional feedback from the British regulator.
Sika said it expects its acquisition of MBCC will be closed in the first half of the year.
Write to Pierre Bertrand at pierre.bertrand@wsj.com
(END) Dow Jones Newswires
April 20, 2023 08:10 ET (12:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month